|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.68 EUR | +0.38% |
|
-1.94% | +16.97% |
| Capitalization | 10.21B 11.99B 9.54B 8.98B 16.53B 1,086B 18.06B 111B 43.2B 512B 44.99B 44.04B 1,868B | P/E ratio 2025 * |
22.6x | P/E ratio 2026 * | 19x |
|---|---|---|---|---|---|
| Enterprise value | 13.92B 16.34B 13B 12.23B 22.52B 1,480B 24.6B 152B 58.86B 698B 61.3B 60.01B 2,545B | EV / Sales 2025 * |
1.9x | EV / Sales 2026 * | 1.77x |
| Free-Float |
66.44% | Yield 2025 * |
1.1% | Yield 2026 * | 1.21% |
Last Transcript: Eurofins Scientific SE
| 1 day | +0.38% | ||
| 1 week | -1.94% | ||
| Current month | -1.64% | ||
| 1 month | -3.06% | ||
| 3 months | -9.62% | ||
| 6 months | -4.38% | ||
| Current year | +16.97% |
| 1 week | 56.34 |  | 58.66 |
| 1 month | 54.86 | | 60.3 |
| Current year | 45.56 | | 69.4 |
| 1 year | 45.56 | | 69.4 |
| 3 years | 39.47 | | 72.12 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 27.12 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 62 | 1986-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 2014-12-31 |
Christian Wurst
PRN | Corporate Officer/Principal | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 62 | 1986-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 59 | 2014-12-31 |
Valérie Hanote
BRD | Director/Board Member | 59 | 1989-12-31 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.47% | 26 M€ | +12.27% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.38% | -1.94% | +20.24% | -14.45% | 11.99B | |
| -1.79% | -5.23% | -3.38% | +8.38% | 45.43B | |
| -1.65% | -1.59% | +11.65% | +2.52% | 37.85B | |
| -0.55% | -1.19% | +77.90% | +53.34% | 35.31B | |
| +0.05% | +1.91% | +5.47% | +18.52% | 27.66B | |
| -1.46% | +1.78% | +61.28% | +159.86% | 15.72B | |
| +0.52% | -0.90% | +75.34% | +238.71% | 15.26B | |
| -1.76% | +0.38% | -10.36% | -5.89% | 14.25B | |
| +4.88% | +7.29% | +69.72% | +79.48% | 13.47B | |
| +2.12% | -1.05% | +120.76% | +111.96% | 13.09B | |
| Average | +0.07% | -0.26% | +42.86% | +65.24% | 23B | |
| Weighted average by Cap. | -0.45% | -1.15% | +34.42% | +49.15% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 7.33B 8.6B 6.84B 6.44B 11.85B 779B 12.95B 79.87B 30.98B 367B 32.27B 31.59B 1,340B | 7.74B 9.09B 7.23B 6.8B 12.53B 823B 13.69B 84.41B 32.74B 388B 34.1B 33.38B 1,416B |
| Net income | 475M 557M 443M 417M 768M 50.47B 839M 5.18B 2.01B 23.79B 2.09B 2.05B 86.8B | 571M 670M 533M 502M 923M 60.67B 1.01B 6.22B 2.41B 28.6B 2.51B 2.46B 104B |
| Net Debt | 3.7B 4.35B 3.46B 3.25B 5.99B 394B 6.55B 40.38B 15.66B 186B 16.31B 15.97B 677B | 3.49B 4.09B 3.26B 3.06B 5.64B 371B 6.16B 38.01B 14.74B 175B 15.36B 15.03B 637B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 57.68 € | +0.38% | 306,420 |
| 25-12-11 | 57.46 € | 0.00% | 230,131 |
| 25-12-10 | 57.46 € | +1.27% | 251,284 |
| 25-12-09 | 56.74 € | -1.42% | 234,966 |
| 25-12-08 | 57.56 € | -2.14% | 322,194 |
Real-time Euronext Paris, December 12, 2025 at 11:55 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition